Hyponatremia-induced osteoporosis.
Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE. · 2010
Read Hyponatremia-induced osteoporosis. by Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3153395.txt.
Introduction
Joseph Verbalis and colleagues linked long-term low blood sodium to bone loss in a 2010 paper in the Journal of Bone and Mineral Research. Low sodium is common in older people and was already tied to unsteady walking and falls. A fall only breaks bones more easily if the bones themselves are weakened, so the team tested both rats and national survey data.
Rats kept low in sodium for three months lost about a third of measured bone density, through faster bone breakdown and slower building. In the human survey, even mild low sodium came with notably higher odds of osteoporosis at the hip. The authors urge bone checks for patients with chronic low sodium, a risk factor hiding in plain sight.
Catalog record
| CREATOR | Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Hyponatremia-Induced Osteoporosis By Joseph G Verbalis, Julianna Barsony, Yoshihisa Sugimura, Ying Tian, Douglas J Adams, Elizabeth A Carter, Helaine E Resnick Published in: Journal of Bone and Mineral Research DOI: 10.1359/jbmr.090827 ABSTRACT Abstract There is a high prevalence of chronic hyponatremia in the elderly, frequently owing to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Recent reports have shown that even mild hyponatremia is associated with impaired gait stability and increased falls. An increased risk of falls among elderly hyponatremic patients represents a risk factor for fractures, which would be further amplified if hyponatremia also contributed metabolically to bone loss. To evaluate this possibility, we studied a rat model of SIADH and analyzed data from the Third National Health and Nutrition Examination Survey (NHANES III). In rats, dual-energy X-ray absorptiometry (DXA) analysis of excised femurs established that hyponatremia for 3 months significantly reduced bone mineral density by approximately 30% compared with normonatremic control rats. Moreover, micro-computed tomography (µCT) and histomorphometric analyses indicated that hyponatremia markedly reduced both trabecular and cortical bone via increased bone resorption and decreased bone formation. Analysis of data from adults in NHANES III by linear regression models showed that mild hyponatremia is associated with increased odds of osteoporosis (T-score –2.5 or less) at the hip [odds ratio (OR) = 2.85; 95% confidence interval (CI) 1.03–7.86; p < .01]; all models were adjusted for age, sex, race, body mass index (BMI), physical activity, history of diuretic use, history of smoking, and serum 25-hydroxyvitamin D [25(OH)D] levels. Our results represent the first demonstration that chronic hyponatremia causes a substantial reduction of bone mass. Cross-sectional human data showing that hyponatremia is associated with significantly increased odds of osteoporosis are consistent with the experimental data in rodents. Our combined results suggest that bone quality should be assessed in all patients with chronic hyponatremia. © 2010 American Society for Bone and Mineral Research. Keywords: hyponatremia, osteoclasts, osteoporosis, aging, syndrome of inappropriate antidiuretic hormone secretion, population studies INTRODUCTION Hyponatremia, defined as serum sodium concentration [Na+] of less than 135 mmol/L, is the most frequently encountered metabolic disorder in clinical practice.(1) It is especially common in elderly individuals, with reported incidences from 7% to 53% in ambulatory and institutionalized geriatric patients, respectively.(2–6) Approximately 50% of chronic hyponatremia is due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).(7,8) Other causes include medications (e.g., diuretics), hypocortisolism, hypothyroidism, hepatic cirrhosis, renal disease, and congestive heart failure.(9–11) Although chronic hyponatremia historically has been difficult to treat, the recent development of oral antagonists to the renal vasopressin V2 receptor offers the likelihood that both acute and chronic hyponatremia will be correctable in the near future.(12,13) Thus this represents a opportune time to evaluate the adverse effects of chronic hyponatremia. Chronic hyponatremia is often described as “asymptomatic” as a result of volume regulatory processes,(14) but potential long-term adverse effects have not been carefully evaluated in controlled studies. Recent reports have suggested that chronic hyponatremia may not be a benign condition.(15–18) Even mild hyponatremia (serum [Na+] = 126 to 134 mmol/L) has been shown to have significant effects on cognitive function and gait stability and has been associated with a 67-fold increased odds ratio for falling compared with normonatremic control individuals.(19) Although an increased risk of falls among elderly hyponatremic patients clearly represents a risk factor for fractures, the risk of fracture would be further amplified if hyponatremia also contributed to bone loss in the elderly. Radioisotope measurements demonstrated that approximately one-third of total-body sodium is stored in bone and that the release of this sodium from bone during prolonged deprivation requires the resorption of bone matrix, similar to the release of stored calcium to compensate for calcium deprivation.(20–23) Despite indications from these classic studies of the importance of bone in sodium homeostasis, the effects of hyponatremia on bone resorption and bone mineralization have not been studied. We therefore initiated these studies to evaluate the possibility that hyponatremia may cause increased bone resorption in an attempt to release body stores of exchangeable sodium. Using an animal model of the human hyponatremic disease SIADH,(24) we monitored changes in trabecular and cortical bone mineral content, histomorphometric parameters of bone resorption and formation, and serum parameters of calcium homeostasis and calcium regulating hormones. We assessed the clinical relevance of our findings by analysis of data from the Third National Health and Nutrition Examination Survey (NHANES III) to test the hypothesis that hyponatremia is independently associated with increased odds of low bone mineral density in a representative sample of US adults aged 50 years and older. MATERIALS AND METHODS Animal model of chronic hyponatremia All experimental procedures were accomplished according to the guidelines in the “Care and Use of Animals,” available at http://www.nap.edu/openbook.php?isbn=0309053773. The Institutional Animal Care and Use Committee of Georgetown University approved all animal experimentation according to federal and institutional policies and regulations. To produce hyponatremia, male albino Sprague-Dawley rats (6 weeks old, 250 to 300 g; Taconic Farms, Germantown, NY, USA) were infused with desmopressin (DDAVP, Aventis, Bridgewater, NJ, USA) at a rate of 5 ng/h via a subcutaneously implanted osmotic minipump (Alzet Model 2004; Durect Co., Cupertino, CA, USA) and were fed 70 mL/d of a nutritionally balanced rodent liquid formula (F1268SP, BioServ, Frenchtown, NJ, USA) at a caloric density of 1.0 kcal/mL.(24) At typical daily intakes, this supplied 30 IU/d of vitamin D3 and 155 mg/d of calcium (5.16 g/kg). Liquid diet was administered via liquid diet feeding tubes (No. 9010, BioServ). Rats were housed intermittently in metabolic cages (No. 650-0100, Nalgene) for 24 hour urine collections. In experiment 1, the control group received a solid diet identical to the liquid diet in composition (AIN-76) and were infused with DDAVP. In experiment 2, one group of control rats received a solid AIN-76 diet and another group the liquid diet without DDAVP. In both experiments, the hyponatremic groups received DDAVP and the liquid diet. Rats in one of the hyponatremic groups and rats on the solid AIN-76 diet in experiment 2 also received biweekly intramuscular injections of 50,000 U/kg vitamin D3 (GeroVitamins, Zalmoxian Products, London, UK). Body weight was measured biweekly. The osmotic minipumps were replaced monthly to maintain constant desmopressin levels. Serum or plasma sodium levels were monitored monthly and remained stable over the duration of the 3 month experiments. Survival blood (2 mL) was collected by tail vein venipuncture under inhalation anesthesia with isoflurane (3% in oxygen at 0.5 L/min). Nonsurvival blood was collected by cardiac puncture, also under isoflurane anesthesia; after blood collection, isoflurane dose was increased until the lack of heart contraction and respiration indicated death. Urine samples were collected over 24 hrs at the end of each month, both with and without preservative. Nine rats per group were studied in experiment 1 and six rats per group in experiment 2. Evaluation of excised bones Bone mineral density (BMD) of excised femora was measured using dual-energy X-ray absorptiometry (DXA) with a small-animal DXA scanner (Piximus II, Lunar GE, Madison, WI, USA) equipped with high-resolution scanning software (Version 2.10). Densitometer stability was tested daily before measurements by scanning a phantom provided by the company. Over the past year, stability was characterized by a coefficient of variation of 0.466% from the last 17 measurements. Additionally, femora were